Direktorat Registrasi ObatValid

ARICEPT EVESS

BPOM Number: DKL2106103281B1
Approved: 17 December 2025
Expiry: 16 December 2030
Form: ORODISPERSIBLE TABLET

About This Registration

ARICEPT EVESS is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL2106103281B1. Its current registration status is Valid, with the licence valid until 16 December 2030. The product is registered to EISAI INDONESIA - INDONESIA. BPOM first approved this registration in December 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DRUM @ 90.000 ORODISPERSIBLE TABLET (KEMASAN BULK)
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

EISAI INDONESIA - INDONESIA
KAB. BOGOR
NPWP: 010005262052000
owner
View profile →

Manufacturing Sites

EISAI INDONESIA - INDONESIA
KAB. BOGOR
primary
View profile →

Ingredients (1)

DONEPEZIL HYDROCHLORIDE

Market Intelligence

Owner Portfolio: EISAI INDONESIA - INDONESIA holds 34 BPOM registrations
Manufacturer Scale: EISAI INDONESIA - INDONESIA produces 34 registered products
Registration Age: Registered for 7 months

FDA Cross-Reference

via openFDA

Generic Name: DONEPEZIL HYDROCHLORIDE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?